Literature DB >> 8616013

PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level.

G Zauli1, A Bassini, L Catani, D Gibellini, C Celeghini, P Borgatti, E Caramelli, L Guidotti, S Capitani.   

Abstract

We investigated whether members of the protein kinase C (PKC) family of enzymes could play a role in the nuclear events involved in megakaryocytic differentiation. PKC activity was analysed using a serine substituted specific peptide, which enabled us to evaluate the whole catalytic activity in the pluripotent haemopoietic HEL cell line treated with 10(-7)M phorbol myristate acetate (PMA) or haemin. In parallel, the subcellular distribution of different PKC isoforms (alpha, beta I, beta II, gamma, delta, epsilon, theta, eta, zeta) was evaluated by Western blot. PKC catalytic activity in the nuclei of HEL cells showed a peak after acute (30 min) treatment with PMA, followed by a significant (P < 0.05) decline after prolonged exposure (72 h) to the same agonist, when most HEL cells had acquired a differentiated megakaryocytic phenotype. Western blot analysis of nuclear lysates consistently showed a significant increase of PKC-alpha, -beta I, -epsilon, theta and -zeta isoforms after 30 min of PMA treatment, followed by a drastic decline of all but PKC-zeta isoforms. Moreover, PKC-6 delta appeared in HEL nuclei only after 72 h of exposure to PMA. On the other hand, neither the catalytic activity nor the immunoreactivity of the different PKC isoforms showed remarkable variations in nuclei of HEL cells induced to differentiate along the erythroid lineage with 10(-7)M haemin. The possible implications of these findings for a better understanding of the molecular events underlying the process of megakaryocytic differentiation are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616013     DOI: 10.1046/j.1365-2141.1996.00384.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Phosphatidylcholine metabolism in nuclei of phorbol ester-activated LA-N-1 neuroblastoma cells.

Authors:  P Antony; J N Kanfer; L Freysz
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

2.  Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple.

Authors:  Cecilia Carubbi; Elena Masselli; Silvia Martini; Daniela Galli; Franco Aversa; Prisco Mirandola; Joseph E Italiano; Giuliana Gobbi; Marco Vitale
Journal:  Haematologica       Date:  2016-04-14       Impact factor: 9.941

3.  Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.

Authors:  Gauthami Jalagadugula; Guangfen Mao; Gurpreet Kaur; Danny N Dhanasekaran; A Koneti Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

4.  Protein kinase C δ deficiency enhances megakaryopoiesis and recovery from thrombocytopenia.

Authors:  John C Kostyak; Dheeraj Bhavanasi; Elisabeta Liverani; Steven E McKenzie; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-30       Impact factor: 8.311

5.  Selective Exo-Enzymatic Labeling Detects Increased Cell Surface Sialoglycoprotein Expression upon Megakaryocytic Differentiation.

Authors:  Seok-Ho Yu; Peng Zhao; Tiantian Sun; Zhongwei Gao; Kelley W Moremen; Geert-Jan Boons; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

6.  A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.

Authors:  K Kollmann; W Warsch; C Gonzalez-Arias; F L Nice; E Avezov; J Milburn; J Li; D Dimitropoulou; S Biddie; M Wang; E Poynton; M Colzani; M R Tijssen; S Anand; U McDermott; B Huntly; T Green
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.